OCC 1.16% 42.5¢ orthocell limited

Ann: Orthocell Appoints Non-Executive Director Dr Ravi Thadhani, page-38

  1. 787 Posts.
    lightbulb Created with Sketch. 126
    Wonder what he has to achieve? If he gets Remplir fda approved and partnered up he deserves every one of the three million shares. Share price should be well on its way to $2 if that happens.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.